Browse Internal Medicine Alert Articles by Topic

Ablation vs. Drug Therapy for Atrial Fibrillation, Revisited

A three-year follow-up of EARLY-AF, a study of relatively young and healthy patients with recent atrial fibrillation, showed cryoablation remains superior to drug therapy for preventing the development of persistent atrial fibrillation.

An Easy Measure of Potentially Harmful Salt Intake

Those who rarely or never added salt to their food and strongly adhered to the Dietary Approaches to Stop Hypertension diet exhibited the lowest incidence of subsequent cardiovascular disease.

Long-Term Air Pollution Exposure Could Raise Risk for Depression, Anxiety

Two research groups reported on breathing dirty air and how that affects mental health.

A Patient with Pneumonia

The ECG in the figure was obtained from an elderly man who was admitted to the hospital with pneumonia. This ECG was obtained after his admission when he began to complain of chest pain. There are two important findings on this patient’s ECG. Can you identify them?

Lecanemab-irmb Injection (Leqembi)

Lecanemab can be prescribed to treat Alzheimer's disease. Initiate this treatment in patients with mild cognitive impairment or mild dementia stage of disease, with confirmation of amyloid beta pathology.

Vaccination Against Mpox: Does It Work? Is It Safe?

Vaccination, either subcutaneously or intradermally, with the non-replicating Jynneos monkeypox vaccine is safe and effective.

Resistance of SARS-CoV-2 Variants to Monoclonal Antibodies

Prevalent SARS-CoV-2 variants are persistently resistant to therapeutic and prophylactic monoclonal antibodies but remain susceptible to nirmatrelvir/ritonavir, remdesivir, and molnupiravir.

Chlorthalidone vs. Hydrochlorothiazide: Which Is Superior for Treating Hypertension?

Randomly switching half of patients with hypertension on hydrochlorothiazide to chlorthalidone did not produce any difference in major cardiovascular outcomes.

For Older Americans, More Steps Lead to Better Cardiovascular Health

In a meta-analysis, researchers found walking 6,000 to 9,000 steps daily lowered the risk of cardiovascular disease by 40% to 50% vs. walking 2,000 steps daily.

Tocilizumab Injection (Actemra)

The FDA has approved tocilizumab injection to treat COVID-19 among hospitalized adult patients who are receiving systemic corticosteroids and require supplemental oxygen.